Breaking News, Promotions & Moves

Valo Health Names New CSO, Karin Conde-Knape

Conde-Knape joins from Novo Nordisk, which has had a collaborative agreement with Valo since 2023.

Author Image

By: Patrick Lavery

Content Marketing Editor

Valo Health has announced its new Chief Scientific Officer (CSO), Karin Conde-Knape, PhD. Conde-Knape succeeds Mike Graziano, PhD, who is retiring as CSO and transitioning to the role of Scientific Advisor for Valo. Valo also recently named a new Chief Financial Officer, Rita Kale. Valo Health Advances With AI As Valo’s mission is using human data and AI to accelerate drug discovery and development, Conde-Knape will oversee various areas. These include the scientific strategy and execut...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters